Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Imunon, Inc.. A complete text table follows the diagram.
RNA and immunotherapy research target new approaches to serious disease.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Total reported revenue | 1 | $59.3M | Reported filing total |
| Immunotherapy development platform | 2 | $59.3M | Company-specific editorial view |
| From | To | Value |
|---|---|---|
| Total reported revenue | Immunotherapy development platform | $59.3M |